ESC Professional Premium Access

Effect of trimetazidine dihydrochloride therapy on myocardial external efficiency in preclinical individuals with an HCM sarcomeric gene mutation

Congress Presentation

About the speaker

Mr Beau Van Driel

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))
0 follower

4 more presentations in this session

State-of-the-art lecture on novel therapies for hypertrophic cardiomyopathy: recent developments and future prospects

Speaker: Doctor C. Ho (Boston, US)

Thumbnail

Long-term safety and efficacy of mavacamten in obstructive hypertrophic cardiomyopathy: up to 3.5-year follow-up results of the EXPLORER cohort of MAVA-Long-Term Extension study

Speaker: Doctor P. Garcia-Pavia (Majadahonda, ES)

Thumbnail

Clinical application of biomarkers in obstructive hypertrophic cardiomyopathy: insights from SEQUOIA-HCM

Speaker: Doctor C. Coats (Glasgow, GB)

Thumbnail

Aficamten in patients with obstructive hypertrophic cardiomyopathy: an integrated safety analysis

Speaker: Doctor A. Masri (Portland, US)

Thumbnail

Access the full session

Novel therapies for hypertrophic cardiomyopathy: recent developments and future prospects

Speakers: Mr B. Van Driel, Doctor C. Ho, Doctor P. Garcia-Pavia, Doctor C. Coats, Doctor A. Masri
Thumbnail

About the event

Image

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations